|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 309.00 ILa | +4.18% |
|
-4.89% | -4.51% |
Business description: InterCure Ltd.
Number of employees: 285
Sales by Activity: InterCure Ltd.
| Fiscal Period: December | 2021 (ILS) | 2022 (ILS) | 2023 (ILS) | 2024 (ILS) | 2025 (ILS) |
|---|---|---|---|---|---|
Cannabis Segment | 220M | 389M | 356M | 239M | 270M |
Geographical breakdown of sales: InterCure Ltd.
| Fiscal Period: December | 2021 (ILS) | 2022 (ILS) | 2023 (ILS) | 2024 (ILS) | 2025 (ILS) |
|---|---|---|---|---|---|
Israel | - | - | - | - | 262M |
Germany | - | - | - | - | 8.15M |
Executive Committee: InterCure Ltd.
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 23/12/2019 | |
Amos Cohen
DFI | Director of Finance/CFO | 47 | 29/02/2020 |
Itai Kabiljo
LAW | General Counsel | - | 31/03/2022 |
Yisrael Gewirtz
AUD | Comptroller/Controller/Auditor | 49 | 31/12/2013 |
Composition of the Board of Directors: InterCure Ltd.
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 55 | 12/02/2025 | |
| Director/Board Member | 65 | 31/10/2020 | |
David Salton
BRD | Director/Board Member | 66 | 13/12/2014 |
| Director/Board Member | 50 | 02/09/2015 | |
| Director/Board Member | 60 | 22/09/2018 |
Company details: InterCure Ltd.
Medical Farming
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.18% | -4.89% | -41.11% | -49.58% | 53.82M | |
| 0.00% | +1.52% | +53.85% | +233.89% | 229M | |
| -2.48% | -4.83% | -30.65% | -34.29% | 140M | |
| -2.67% | -0.55% | -3.70% | +102.22% | 130M | |
| +0.41% | +4.94% | -8.62% | +0.42% | 90.86M | |
| +6.17% | +2.38% | +14.67% | -41.89% | 82.2M | |
| Average | +0.99% | -3.86% | -2.60% | +35.13% | 121.09M | |
| Weighted average by Cap. | +0.17% | -1.78% | +7.94% | +77.14% |
- Stock Market
- Stocks
- INCR Stock
- Company InterCure Ltd.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
